Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Fujii

Showing results (271-280 of 283) with videos related to

Pageof 29
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2019
Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy studyRyosuke Tarumi, Sakiko Tsugawa, Yoshihiro Noda, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 22, 2020
White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging studyRyo Ochi, Yoshihiro Noda, Shohei Tsuchimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 28, 2019
[A Case of Pulmonary Enteric Adenocarcinoma with Soleus Muscle Metastasis]Takafumi Suzuki, Haruhiko Furusawa, Yuta Watanabe, et al.
Schizophrenia Research|January 15, 2023
Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophreniaKamiyu Ogyu, Karin Matsushita, Shiori Honda, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2025
Associations of neuromelanin in the substantia nigra with antipsychotic response in schizophreniaRyosuke Tarumi, Shiori Honda, Clifford Cassidy, et al.
Schizophrenia Research|February 16, 2023
Impaired mismatch negativity reflects the inability to perceive beat interval in patients with schizophreniaYuichi Takahashi, Shinya Fujii, Yusuke Osakabe, et al.
Schizophrenia Research|May 26, 2020
Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation studyTsutomu Takahashi, Sakiko Tsugawa, Shinichiro Nakajima, et al.
Cell Death & Disease|June 12, 2023
Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoidXian-Yang Qin, Yutaka Furutani, Kento Yonezawa, et al.
JACC. Cardiovascular Interventions|January 4, 2023
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary InterventionKo Yamamoto, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Circulation. Cardiovascular Interventions|May 18, 2021
Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insight From the STOPDAPT-2 TrialKo Yamamoto, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Pageof 29

Showing results (271-280 of 283) with videos related to

Sort By:
Pageof 29
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 17, 2019
Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy studyRyosuke Tarumi, Sakiko Tsugawa, Yoshihiro Noda, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 22, 2020
White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging studyRyo Ochi, Yoshihiro Noda, Shohei Tsuchimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 28, 2019
[A Case of Pulmonary Enteric Adenocarcinoma with Soleus Muscle Metastasis]Takafumi Suzuki, Haruhiko Furusawa, Yuta Watanabe, et al.
Schizophrenia Research|January 15, 2023
Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophreniaKamiyu Ogyu, Karin Matsushita, Shiori Honda, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 7, 2025
Associations of neuromelanin in the substantia nigra with antipsychotic response in schizophreniaRyosuke Tarumi, Shiori Honda, Clifford Cassidy, et al.
Schizophrenia Research|February 16, 2023
Impaired mismatch negativity reflects the inability to perceive beat interval in patients with schizophreniaYuichi Takahashi, Shinya Fujii, Yusuke Osakabe, et al.
Schizophrenia Research|May 26, 2020
Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation studyTsutomu Takahashi, Sakiko Tsugawa, Shinichiro Nakajima, et al.
Cell Death & Disease|June 12, 2023
Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoidXian-Yang Qin, Yutaka Furutani, Kento Yonezawa, et al.
JACC. Cardiovascular Interventions|January 4, 2023
Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary InterventionKo Yamamoto, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Circulation. Cardiovascular Interventions|May 18, 2021
Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insight From the STOPDAPT-2 TrialKo Yamamoto, Hirotoshi Watanabe, Takeshi Morimoto, et al.
Pageof 29